Consistent Year-Round Supply Icon
Bioreactor production algae or microbes eliminates dependence on seasonal seaweed harvests and geographical location.
Carrageenan is a family of linear sulfated polysaccharides used extensively as Thickeners/Gels in food, cosmetics, and pharmaceuticals. The primary supply chain faces significant limitations: Extraction from red seaweed is seasonal and requires harsh chemical treatment alkali to convert kappa/iota precursors into the final gelling form. This leads to inconsistent supply and high processing costs.
CD Biosynsis offers a sustainable and controlled biomanufacturing route for Carrageenan and its analogs: Cultivation: Controlled cultivation of specific microalgae species that produce Carrageenan-like sulfated polysaccharides. This provides a reliable, non-seasonal source. More advanced control is achieved via Genetic Engineering: Map and transfer the Sulfotransferase and Glycosyltransferase pathways to an industrial microbial host for controlled synthesis. This approach allows for the precise, controlled synthesis of specific Carrageenan types e.g. kappa, iota in a robust, scalable microbial platform.
Get a QuoteThe supply and quality of Carrageenan face these critical hurdles:
A bio-based approach must provide a reliable, controlled synthesis route for specific Carrageenan types, eliminating chemical modification.
CD Biosynsis utilizes genetic engineering and advanced cultivation to optimize Carrageenan production:
Controlled Microalgae Cultivation
We establish controlled bioreactor cultivation of fast-growing microalgae strains that naturally produce or are engineered to produce Carrageenan analogs, ensuring year-round, consistent supply.
Synthetic Pathway Transfer
We map and transfer the key Glycosyltransferase and Sulfotransferase enzymes responsible for the backbone synthesis and sulfation pattern to industrial microbial hosts e.g. yeast.
In-Vivo Functionalization
We engineer the host to express the necessary deacetylase and cyclase enzymes that catalyze the in-vivo formation of the functional 3,6-anhydro bridge, eliminating the need for harsh alkali treatment.
Precise Type Control
By controlling the expression and specificity of Sulfotransferase enzymes, we achieve precise control over the sulfation pattern, allowing for pure kappa or pure iota Carrageenan synthesis.
This combined strategy enables the production of designer Carrageenan types with high purity and consistency.
Our Carrageenan engineering service is dedicated to pursuing the following production goals:
Consistent Year-Round Supply Icon
Bioreactor production algae or microbes eliminates dependence on seasonal seaweed harvests and geographical location.
Green Chemistry Process Icon
Biological in-vivo functionalization avoids the use of harsh, corrosive alkali chemicals in processing.
Tunable Product Properties Icon
Genetic control allows for synthesis of pure kappa or iota Carrageenan, tailoring the final gelling behavior.
High Purity and Consistency Icon
Microbial synthesis ensures a narrow molecular weight distribution and consistent quality, unlike mixed seaweed extracts.
Enhanced Bioreactor Scalability Icon
Using robust microbial hosts allows for efficient, scalable fermentation in conventional bioreactors.
We deliver a next-generation Carrageenan supply with improved environmental and economic profiles.
Our Carrageenan engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a designer, high-purity Carrageenan supply. CD Biosynsis provides customized strain and process engineering solutions:
What is the significance of the 3,6-anhydro bridge in Carrageenan?
The 3,6-anhydro bridge is the structural feature critical for the Carrageenan to form gels. Without this ring structure, the polymer remains linear and non-gelling lambda Carrageenan used as a thickener. The traditional process uses harsh alkali to create this bridge; our genetic engineering solution uses a cyclase enzyme for in-vivo enzymatic formation, achieving the gelling property through a green process.
How does controlling Sulfotransferase activity produce kappa vs iota Carrageenan?
The difference between the various types kappa, iota, lambda lies in the number and position of sulfate groups attached to the galactose units. Sulfotransferase enzymes are responsible for these modifications. By controlling which specific Sulfotransferase genes are expressed and at what level, we can precisely dictate the sulfation pattern and thus synthesize a pure, single Carrageenan type, which is impossible with natural extraction.
What is the advantage of using microalgae cultivation as a supply route?
Microalgae can be cultivated in closed bioreactors or open ponds year-round, eliminating the seasonality and geographic dependence of seaweed harvesting. Furthermore, microalgae offer much faster growth rates and more controlled growth environments, allowing for process optimization and a more stable, scalable biomass source for the Carrageenan precursor extraction.
Does the microbial host switch affect the product quality?
The Carrageenan product quality is determined by the activity and specificity of the transferred enzymes, not the host itself. By ensuring the entire synthesis pathway is functional in the new host, we gain greater control over purity and consistency. The robust industrial host simply acts as a more efficient, higher-yield biological factory for the engineered pathway.
What is the estimated project timeline?
A comprehensive project involving pathway mapping, host engineering, sulfation tuning, and fermentation optimization typically requires 34-45 weeks for final strain delivery and validated custom Carrageenan production protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.